Vor Biopharma Inc.

VOR · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.7B · 168 employees
87
SEC Filings
$15.52
Close 2026-05-27
168
Employees

Business Summary

4 Item 1A. Risk Factors 30 Item 1B. Unresolved Staff Comments 81 Item 1C. Cybersecurity 81 Item 2. Properties 82 Item 3. Legal Proceedings 82 Item 4. Mine Safety Disclosures 82 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 83 Item 6. [Reserved] 83 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 84 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 95 Item 8....

Latest Stock Quote

VOR 2026-05-27 $15.52 O:$14 H:$15.59 L:$13.95 Vol:0.8M VWAP:$15.1912
origin leaf: e8a8111652520124cca4395da7b0868615bf66367dc27fee08fc182729b023a0

Next Earnings

Q2 FY2026 — expected 2026-09-17

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001193125-26-130451EDGAR84K words
2025-03-202024-12-310000950170-25-042623EDGAR
2024-03-202023-12-310000950170-24-034146EDGAR
2023-03-232022-12-310000950170-23-009472EDGAR
2022-03-142021-12-310000950170-22-003577EDGAR
2021-03-252020-12-310001564590-21-015474EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001193125-25-280104EDGAR56K words
2025-08-122025-06-300000950170-25-107276EDGAR
2025-05-142025-03-310000950170-25-071349EDGAR
2024-11-072024-09-300000950170-24-123245EDGAR
2024-08-082024-06-300000950170-24-093858EDGAR
2024-05-092024-03-310000950170-24-056846EDGAR
2023-11-072023-09-300000950170-23-060200EDGAR
2023-08-102023-06-300000950170-23-041272EDGAR
2023-05-112023-03-310000950170-23-021188EDGAR
2022-11-102022-09-300000950170-22-024444EDGAR
2022-08-112022-06-300000950170-22-016853EDGAR
2022-05-122022-03-310000950170-22-009649EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-270001193125-26-127609EDGAR18K words
2026-01-120001193125-26-009961EDGAR
2026-01-020001193125-26-000905EDGAR
2025-12-180001193125-25-324768EDGAR
2025-12-090001193125-25-311957EDGAR
2025-11-120001193125-25-275862EDGAR
2025-11-030001193125-25-261723EDGAR
2025-10-280001193125-25-253636EDGAR
2025-09-170001193125-25-205553EDGAR
2025-09-020001193125-25-193600EDGAR

87 total filings indexed. 59 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001817229
TickerVOR
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
Websitehttps://www.vorbio.com
Listed2021-02-05

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 64f7443e2330bee6252eee3c99c9ded201f930ac956b60d2af05dd0704a317e6
parent: 2980eeb60a90d2dd8fdbf91f3d82031da29d19e73f4659d4a692cdeefc7bb00b
content hash: ca79ba9e5898ac8317eb50f89d2afca66597b8afb093c953d7109ffda3bb8795
signed: 2026-06-02T19:03:03.436Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf